Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics

References

• Murray CJ, Lopez AD. Mortality by cause for eight regions of the world, global burden of disease study. Lancet 349, 1269–1276 (1997).
   Google Scholar
• Houston MC, Fazio S, Chilton FH et al. Nonpharmacologic treatment of dyslipidemia. Prog. Cardiovasc. Dis. 52, 61–94 (2009).
   Google Scholar
• Harris WS, Miller M, Tighe AP et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12–24 (2008).
   Google Scholar
• Santo AS, Santo AM, Browne RW et al. Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile. Lipids 45, 1127–1138 (2010).
   Google Scholar
• McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J. Chiropr. Med. 7, 48–58 (2008).
   Google Scholar
• Bazzano LA, Thompson AM, Tees MT et al. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 21, 94–103 (2011).
   Google Scholar
• Venero CV, Venero JV, Wortham DC et al. Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am. J. Cardiol. 105, 664–666 (2010).
   Google Scholar
• Guarner, F, Schaafsma GJ. Probiotics. Int. J. Food Microbiol. 39, 237–238 (1998).
   Google Scholar
• Del Piano M, Morelli L. Probiotics: from research to consumer. Dig. Liver Dis. 38, 248–255 (2006).
   Google Scholar
• Mann GV, Spoerry A. Studies of a surfactant and cholesterolemia in the Maasai. Am. J. Clin. Nutr. 27, 464–469 (1974).
   Google Scholar
• Agerbaek M, Gerdes LU, Richelsen B et al. Hypocholesterolaemic effect of a new fermented milk product in healthy middleaged men. Eur. J. Clin. Nutr. 49, 346–352 (1995).
   Google Scholar
• Anderson JW, Gilliland SE. Effect of fermented milk yogurt containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18, 43–50 (1999).
   Google Scholar
• Ataie-Jafari A, Larijani B, Majd HA et al. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 54, 22–27 (2009). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A et al. The effects of probiotic and conventional yoghurt on lipid profile in women. Br. J. Nutr. 103, 1778–1783 (2010). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Bertolami, MC, Faludi AA, Batlouni M et al. Evaluation of the effects of a new fermented milk product Gaio on primary hypercholesterolemia. Eur. J. Clin. Nutr. 53, 97–101 (1999).
   Google Scholar
• de Roos NM, Schouten G, Katan MB. Yogurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur. J. Clin. Nutr. 53, 277–280 (1999).
   Google Scholar
• Agerholm-Larsen L, Raben A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur. J. Clin. Nutr. 54, 288–297 (2000). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Naruszewicz M, Johansson ML, Zapolska-Downar D et al. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76, 1249–1255 (2002).
   Google Scholar
• Xiao JZ, Kondo S, Takahashi S. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J. Dairy Sci. 86, 2452–2461 (2003). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Fabian E, Elmadfa I. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann. Nutr. Metab. 50, 387–393 (2006).
   Google Scholar
• Simons LA, Armansec SG, Conway P et al. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum. Nutr. Metab. Cardiovasc. Dis. 16, 531–535 (2006).
   Google Scholar
• Glass GV. Primary, secondary, and meta-analysis of research. Educat. Res. 5, 3–8 (1976).
   Google Scholar
• Agerholm-Larsen L, Bell ML, Grunwald GK et al. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur. J. Clin. Nutr. 54, 856–860 (2000). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Guo Z, Liu XM, Zhang QX et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr. Metab. Cardiovasc. Dis. 21, 844–850 (2011). ▪ Reported clinical outcome of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int. J. Mol. Sci. 11, 2499–2522 (2010).
   Google Scholar
• Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49, 377–381 (1985).
   Google Scholar
• Kimoto H, Ohmomo S, Okamoto T. Cholesterol removal from media by Lactococci. J. Dairy Sci. 85, 3182–3188 (2002).
   Google Scholar
• Sirilun S, Chaiyasut C, Kantachote D et al. Characterisation of non human origin probiotic Lactobacillus plantarum with cholesterol-lowering property. Afr. J. Microbiol. Res. 4, 994–1000 (2010).
   Google Scholar
• Lye HS, Rusul G, Liong MT. Removal of cholesterol by Lactobacilli via incorporation of and conversion to coprostanol. J. Dairy Sci. 93, 1383–1392 (2010).
   Google Scholar
• Liong MT, Shah NP. Acid and bile tolerance and the cholesterol removal ability of Lactobacilli strains. J. Dairy. Sci. 88, 55–66 (2005).
   Google Scholar
• Lye HS, Rahmat-Ali GR, Liong MT. Mechanisms of cholesterol removal by Lactobacilli under conditions that mimic the human gastrointestinal tract. Int. Dairy J. 20, 169–175 (2010).
   Google Scholar
• Liong MT, Shah NP. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of Lactobacilli strains. Int. Dairy. J. 15, 391–398 (2005).
   Google Scholar
• Perova NV, Metelskaya VA. [Plant sterols and stanols as the dietary factors lowering hypercholesterolemia by inhibition of intestinal cholesterol absorption.] Kardiologiia. 48, 62–69 (2008).
   Google Scholar
• Jia LJ, Betters L, Yu L et al. Niemann-Pick C1-Like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu. Rev. Physiol. 73, 239–259 (2011).
   Google Scholar
• Davis Hr Jr, Zhu LJ, Hoos LM et al. Niemann-Pick C1 Like 1 NPC1L1 is the intestinal phytosterol and cholesterol transporter and a key modulator of wholebody cholesterol homeostasis. J. Biol Chem. 279, 33586–33592 (2004).
   Google Scholar
• Huang Y, Wang J, Cheng Y et al. The hypocholesterolaemic effects of Lactobacillus acidophilus American Type Culture Collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-Like 1. Br. J. Nutr. 104, 807–812 (2010).
   Google Scholar
• Duval C, Touche V, Tailleux A et al. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem. Biophys. Res. Commun. 340, 1259–1263 (2006).
   Google Scholar
• Huang Y, Zheng YC. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br. J. Nutr. 103, 473–478 (2010). ▪ Reports potential mechanisms of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Ikonen E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol. Rev. 86, 1237–1261 (2006).
   Google Scholar
• DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18, 609–619 (2008).
   Google Scholar
• Jeun J, Kim S, Cho SY et al. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 26, 321–330 (2010). ▪ Reports potential mechanisms of the cholesterol-lowering effects of probiotics.
   Google Scholar
• Park YH, Kim JG, Shin YW et al. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J. Microbiol. Biotechnol. 17, 655–662 (2007).
   Google Scholar
• Peterson DA, Frank DN, Pace NR et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3, 417–427 (2008).
   Google Scholar
• Gophna U, Sommerfeld K, Gophna S et al. Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136–4141 (2006).
   Google Scholar
• Koren O, Spor A, Felin J et al. Microbes and health sackler colloquium: human oral, gut, and plaque microbiota in patients with atherosclerosis. PNAS 108, 4592–4598 (2010). ▪▪ Reports the relationship between microbial constitution and hyperlipidemia, which may help us understand the possibilities for treating hyperlipidemia through changing the composition of microbes by oral prebiotics.
   Google Scholar
• Hatakka K, Ahola AJ, Yli-Knuuttila H et al. Probiotics reduce the prevalence of oral Candida in the elderly – a randomized controlled trial. J. Dent .Res. 86, 125–130 (2007).
   Google Scholar
• Ahola AJ, Yli-Knuuttila H, Suomalainen T et al. Short-term consumption of probioticcontaining cheese and its effect on dental caries risk factors. Arch. Oral Biol. 47, 799–804 (2002).
   Google Scholar
• Kaushik JK, Kumar A, Duary RK et al. Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS ONE 4, 8099–8110 (2009).
   Google Scholar